Unknown

Dataset Information

0

Anti-high mobility group box-1 (HMGB1) antibody attenuates delayed cerebral vasospasm and brain injury after subarachnoid hemorrhage in rats.


ABSTRACT: Although delayed cerebral vasospasm (DCV) following subarachnoid hemorrhage (SAH) is closely related to the progression of brain damage, little is known about the molecular mechanism underlying its development. High mobility group box-1 (HMGB1) plays an important role as an initial inflammatory mediator in SAH. In this study, an SAH rat model was employed to evaluate the effects of anti-HMGB1 monoclonal antibody (mAb) on DCV after SAH. A vasoconstriction of the basilar artery (BA) associated with a reduction of nuclear HMGB1 and its translocation in vascular smooth muscle cells were observed in SAH rats, and anti-HMGB1 mAb administration significantly suppressed these effects. Up-regulations of inflammation-related molecules and vasoconstriction-mediating receptors in the BA of SAH rats were inhibited by anti-HMGB1 mAb treatment. Anti-HMGB1 mAb attenuated the enhanced vasocontractile response to thrombin of the isolated BA from SAH rats and prevented activation of cerebrocortical microglia. Moreover, locomotor activity and weight loss recovery were also enhanced by anti-HMGB1 mAb administration. The vasocontractile response of the BA under SAH may be induced by events that are downstream of responses to HMGB1-induced inflammation and inhibited by anti-HMGB1 mAb. Anti-HMGB1 mAb treatment may provide a novel therapeutic strategy for DCV and early brain injury after SAH.

SUBMITTER: Haruma J 

PROVIDER: S-EPMC5121891 | biostudies-other | 2016 Nov

REPOSITORIES: biostudies-other

altmetric image

Publications

Anti-high mobility group box-1 (HMGB1) antibody attenuates delayed cerebral vasospasm and brain injury after subarachnoid hemorrhage in rats.

Haruma Jun J   Teshigawara Kiyoshi K   Hishikawa Tomohito T   Wang Dengli D   Liu Keyue K   Wake Hidenori H   Mori Shuji S   Takahashi Hideo Kohka HK   Sugiu Kenji K   Date Isao I   Nishibori Masahiro M  

Scientific reports 20161124


Although delayed cerebral vasospasm (DCV) following subarachnoid hemorrhage (SAH) is closely related to the progression of brain damage, little is known about the molecular mechanism underlying its development. High mobility group box-1 (HMGB1) plays an important role as an initial inflammatory mediator in SAH. In this study, an SAH rat model was employed to evaluate the effects of anti-HMGB1 monoclonal antibody (mAb) on DCV after SAH. A vasoconstriction of the basilar artery (BA) associated wit  ...[more]

Similar Datasets

| S-EPMC8293512 | biostudies-literature
2014-05-08 | E-GEOD-37924 | biostudies-arrayexpress
2014-05-08 | GSE37924 | GEO
| S-EPMC4415505 | biostudies-literature
| S-EPMC5573230 | biostudies-other
| S-EPMC2773037 | biostudies-other
2021-06-02 | GSE165608 | GEO
| S-EPMC8163224 | biostudies-literature
| S-EPMC3271157 | biostudies-literature